GlassScriptPhysician profile
Peter Y Hahn
NPI 1588642359
$5,851.29
in general payments reported to CMS, 2019-2025
11 companies · $5,579 in 2025
The $5,579 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.90 · 2022: $94.46 · 2023: $19.00 · 2024: $77.18 · 2025: $5,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,726 · Education: $2,600 · Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,725.57 |
| Education | $2,599.95 |
| Food and Beverage | $349.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,338.58 | 2022-2025 | Da Vinci Surgical System |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Janssen Biotech, INC. | $81.90 | 2019 | |
| Jazz Pharmaceuticals INC. | $77.18 | 2024 | |
| Glaxosmithkline, LLC. | $66.63 | 2025 | Nucala, Shingrix |
| Verona Pharma, INC. | $48.88 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $40.96 | 2025 | Tezspire, Breztri |
| Insmed, INC. | $32.16 | 2025 | Brinsupri, Arikayce |
| Regeneron Healthcare Solutions, INC. | $26.84 | 2025 | Dupixent |
| Viatris Specialty LLC | $22.95 | 2025 | Yupelri |
| Baxter Healthcare | $15.26 | 2025 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.